Document:

EX-10.1

REAFFIRMATION AGREEMENT

THIS REAFFIRMATION AGREEMENT (this “Agreement”) is made as of September 22, 2014, by the
undersigned in favor of ACF FINCO I LP (“Lender”).

RECITALS:

Keltic Financial Partners II, LP sold substantially all of its assets to, and transferred
substantially all of its liabilities to, ACF FINCO I LP, a Delaware limited partnership (“Lender”)
effective June 4, 2014 pursuant to the terms of an Asset Purchase Agreement dated May 12, 2014 and
the other agreements, documents and instruments executed and/or delivered in connection therewith
(the “Keltic Acquisition”). CASTLE BRANDS INC., a corporation organized under the laws of the
State of Florida (“CBI”) and CASTLE BRANDS (USA) CORP. a corporation organized under the laws of
the State of Delaware (“CBUSA”) (individually and collectively, “Borrower”) and Lender (as
successor-in-interest to Keltic Financial Partners II, LP pursuant to the Keltic Acquisition), are
parties to a Loan and Security Agreement dated as of August 19, 2011, as amended by a First
Amendment effective July 23, 2012, by an Second Amendment effective March 11, 2013, by a Third
Amendment effective August 7, 2013, by a Fourth Amendment, Waiver and Consent effective October 21,
2013, by a Fifth Amendment, Waiver and Consent effective November 14, 2013 and by a Sixth Amendment
effective as of June 30, 2014 (as so amended, the “Credit Agreement”), in connection with which
Borrower delivered an Amended and Restated Revolving Credit Note dated March 11, 2013 in a maximum
principal amount of $8,000,000 (the “Revolving Credit Note”), an Amended and Restated Term Note
dated August 7, 2013 in an original principal amount of $4,000,000, an Amended and Restated
Participation Agreement dated August 7, 2013 between Lender and the parties executing the same as
“Participants” (the “Participation Agreement”) a Subordination Agreement dated August 7, 2013, as
amended by a First Amendment effective as of October 21, 2013 between Lender and the parties
executing the same as “Junior Creditors” thereto (as so amended, the “Subordination Agreement”),
and other agreements, documents and instruments in connection therewith.

The Credit Agreement, the Revolving Credit Note, the Term Note, the Participation Agreement, the
Subordination Agreement, and all other agreements, documents and instruments executed and/or
delivered in connection therewith, as the same may be amended, restated, or otherwise modified from
time to time, shall be collectively referred to as the “Loan Documents”.

Borrower has requested that Lender amend and restate the Credit Agreement to incorporate all
amendments and modifications made thereto, to permit CBI to repay in full the indebtedness and
obligations evidenced by the CBI August 2013 Subordinated Loan Documents, to amend and restate the
Credit Agreement and Revolving Credit Note to increase the amount of the Revolving Credit and
extend the term of the Revolving Credit to July 31, 2019, to amend and restate the Term Note to
extend the term of the Term Loan to July 31, 2019, to amend the Subordination Agreement to permit
the repayment in full of CBI’s indebtedness and obligations under the CBI August 2013 Subordinated
Loan Documents, and to make certain other changes as described in an Amended and Restated Loan and
Security Agreement effective on or about the date hereof (the “Restated Credit Agreement”), an
Amended and Restated Revolving Credit Note dated on or about the date hereof (the “Restated
Revolving Credit Note”), an Amended and Restated Term Note date on or about the date hereof (the
“Restated Term Note”) and the other agreements, documents instruments executed and/or delivered to
Senior Creditor in connection therewith. For purposes of this Agreement, the Restated Credit
Agreement, the Restated Revolving Credit Note, the Restated Term Note, and all agreements,
documents and instruments executed and/or delivered to Lender in connection therewith shall be
referred to as the “Credit Agreement Restatement Documents”.

Each of the undersigned indicated as a “Validity Party” has executed and delivered a Validity and
Support Agreement dated on or about August 19, 2011 in favor of Lender (each, a “Validity
Agreement”) pursuant to which such Validity Party has agreed to validate certain information
provided by Borrower to Lender and provide support in connection with Lender’s efforts to collect
collateral to secure Borrower’s payment and performance of all obligations and to Lender and such
other matters as described in such Validity Agreement.

Each of the undersigned indicated as a “Term Loan Participant” has executed and delivered to Lender
the Participation Agreement pursuant to which such Participant has agreed to participate in the
Term Note and to such other matters upon such terms and conditions contained in the Participation
Agreement.

Each of the undersigned indicated as a “Junior Creditor” has executed and delivered to Lender the
Subordination Agreement pursuant to which such Junior Creditor has agreed to subordinate its rights
to payment of indebtedness due from Borrower to the indebtedness of Borrower to Lender, and such
other matters upon such terms and conditions contained in the Subordination Agreement.

Upon the terms and conditions contained in the Credit Agreement Restatement Documents Lender has
agreed to amend and restate the Credit Agreement and make certain other changes to the Credit
Agreement, among other things, subject to and conditioned on the execution and delivery of this
Agreement by the undersigned to Lender.

AGREEMENT:

1. Notwithstanding the occurrence of any of the events described in the recitals hereto or
anything to the contrary contained in any of the Credit Agreement Restatement Documents or the
other Loan Documents, Borrower hereby (a) ratifies and confirms that pursuant to the transactions
effected by the Keltic Acquisition effective June 4, 2014 ACF FinCo I LP is the “Lender” for all
purposes of the Loan Documents, (b) reaffirms to Lender and ratifies its obligations under the
Credit Agreement Restatement Documents and the other Loan Documents (collectively, the “Keltic
Obligations”), including, specifically, the Credit Agreement Restatement Documents, and as the Loan
Documents may have been amended, modified and/or restated from time to time and including the
amendment, modification or restatement thereof in connection with the matters described in the
recitals hereto, and each other agreement, document and instrument executed and/or delivered by the
Borrower in connection therewith as the same may have been amended, modified and/or restated from
time to time and including the amendment, modification or restatement thereof in connection with
the matters described in the recitals hereto (collectively, the “Borrower Documents”), and (c)
further ratifies and confirms that each of the Borrower Documents shall remain in full force and
effect.

2. Notwithstanding the occurrence of any of the events described in the recitals hereto or
anything to the contrary contained in such party’s Validity Agreement, each Validity Party hereby
(a) ratifies and confirms that pursuant to the transactions effected by the Keltic Acquisition
effective June 4, 2014 ACF FinCo I LP is the “Lender” for all purposes of the Loan Documents, (b)
reaffirms to Lender and ratifies its obligations under such Validity Agreement, and each other
agreement, document and instrument executed and/or delivered by such Validity Party in connection
therewith, as the same may have been amended, modified and/or restated from time to time
(collectively, the “Validity Documents”), and (c) further ratifies and confirms that each of the
Validity Documents executed and/or delivered to Lender shall remain in full force and effect.

3. Notwithstanding the occurrence of any of the events described in the recitals hereto or
anything to the contrary contained in the Participation Agreement, each Term Loan Participant
hereby (a) ratifies and confirms that pursuant to the transactions effected by the Keltic
Acquisition effective June 4, 2014 ACF FinCo I LP is the “Lender” for all purposes of the Loan
Documents, (b) reaffirms to the Lender and ratifies its obligations under the Participation
Agreement, and each other agreement, document and instrument executed and/or delivered by such
Participant in connection therewith, as the same may have been amended, modified and/or restated
from time to time (collectively, the “Participation Documents”), and (c) further ratifies and
confirms that each of the Participation Documents executed and/or delivered to Lender shall remain
in full force and effect.

4. Notwithstanding the occurrence of any of the events described in the recitals hereto or
anything to the contrary contained in the Subordination Agreement, each Junior Creditor hereby (a)
ratifies and confirms that pursuant to the transactions effected by the Keltic Acquisition
effective June 4, 2014 ACF FinCo I LP is the “Lender” for all purposes of the Loan Documents, and
that ACF FinCo I LP is the “Senior Creditor” for all purposes of the Subordination Agreement,
specifically including the Second Amendment of the Subordination Agreement dated on or about the
date of this Agreement, (b) reaffirms to Lender and ratifies its obligations under the
Subordination Agreement, and each other agreement, document and instrument executed and/or
delivered by such Junior Creditor in connection therewith, as the same may have been amended,
modified and/or restated from time to time (collectively, the “Subordination Documents”), and (c)
further ratifies and confirms that each of the Subordination Documents executed and/or delivered to
Senior Creditor shall remain in full force and effect.

5. No change, amendment or modification of this Agreement shall be valid or binding unless
such change, amendment or modification shall be in writing and duly executed by all parties hereto
and consented to by the Lender in writing.

6. This Agreement shall be governed by and interpreted and construed in accordance with the
internal laws of the State of New York, without regard to its principles of conflicts of laws, and
any dispute hereunder shall be brought in the appropriate court located in Westchester County, New
York or Erie County, New York.

7. This Agreement may not be assigned by any party hereto without the prior written consent of
the other parties hereto and the Lender, and no party hereto shall be relieved of its duties,
obligations or liabilities under this Agreement without the express written consent of the other
parties hereto and the Lender, regardless of assignments, delegations or other agreements with
third parties which may provide otherwise.

8. This Agreement shall be binding upon the parties hereto, their successors, permitted
assigns, heirs and legal representatives.

9. The invalidity of one or more phrases, sentences, clauses or paragraphs contained in this
Agreement shall not affect the validity of the remainder of this Agreement.

10. This Agreement contains the entire understanding of the parties and the Lender with
respect to the subject matter hereof and there are no other oral understandings, terms or
conditions except as expressly stated herein and none of the parties have relied upon any
representation, express or implied, not contained in this Agreement.

11. This Agreement may be executed in two (2) or more counterparts, each of which shall be
considered an original, and all of which shall be considered one and the same instrument.

IN WITNESS WHEREOF, the undersigned have duly executed this Agreement as of the date first
written above.

BORROWER:

	 	 	 
	CASTLE BRANDS INC.

	 	CASTLE BRANDS (USA) CORP.
	By: /s/ Alfred J. Small

	 	By: /s/ Alfred J. Small
	 

	 	 
	Name: Alfred J. Small

	 	Name: Alfred J. Small
	 

	 	 
	Its: CFO

	 	Its:CFO
	 

	 	 
	VALIDITY PARTIES:

	 	

	/s/ Alfred Small

	 	/s/ John Glover
	 

	 	 
	ALFRED SMALL

	 	JOHN GLOVER
	/s/ Michael Becker

	 	/s/ T. Kelley Spillane
	 

	 	 
	MICHAEL BECKER

	 	T. KELLEY SPILLANE
	TERM LOAN PARTICIPANTS:

	 	

	FROST GAMMA INVESTMENTS TRUST

	 	MARIN BLEU INC.
	By: /s/ Phillip Frost, M.D.

	 	By:/s/ Stephen Liu
	 

	 	 
	Name: Phillip Frost, M.D.

	 	Name:Stephen Liu
	 

	 	 
	Its: Trustee

	 	Its:President/Director
	 

	 	 
	/s/ Mark E. Andrews, III

	 	/s/ Susan M. Lampen
	 

	 	 
	MARK E. ANDREWS, III

	 	SUSAN M. LAMPEN
	/s/ Michael S. Liebowitz

	 	/s/ Chester Franklin Zoeller III
	 

	 	 
	MICHAEL S. LIEBOWITZ

	 	CHESTER FRANKLIN ZOELLER III
	JUNIOR CREDITORS:

	 	

	FROST GAMMA INVESTMENTS TRUST

	 	THREE COURT MASTER, LP
	By: /s/ Phillip Frost, M.D.

	 	By: /s/ Arthur Y. Roulac
	 

	 	 
	Name: Phillip Frost, M.D.

	 	Name: Arthur Y. Roulac
	 

	 	 
	Its: Trustee

	 	Its: Partner
	 

	 	 

JACQUELINE SIMKIN TRUST AS AMENDED DAVID THALHEIM REVOCABLE LIVING

	 	 	 
	AND RESTATED 12/16/2003

	 	TRUST
	By: /s/ Jacqueline Simkin

	 	By: /s/ David Thalheim
	 

	 	 
	Name: Jacqueline Simkin

	 	Name: David Thalheim
	 

	 	 
	Its: Trustee

	 	Its: Trustee
	 

	 	 
	IVC INVESTORS, LLLP

	 	VECTOR GROUP LTD
	By: /s/ Glenn L. Halpryn

	 	By: /s/ J. Bryant Kirkland III
	 

	 	 
	Name: Glenn L. Halpryn

	 	Name: J. Bryant Kirkland III
	 

	 	 
	Its: President

	 	Its: Vice President, CFO and Treasurer
	 

	 	 
	/s/ Susan M. Lampen

	 	/s/ Mark E. Andrews, III
	 

	 	 
	SUSAN M. LAMPEN

	 	MARK E. ANDREWS, III
	/s/ Brian Heller

	 	/s/ Michael Brauser
	 

	 	 
	BRIAN HELLER

	 	MICHAEL BRAUSER
	/s/ Subbarao Uppaluri

	 	/s/ Juan Rodriguez
	 

	 	 
	SUBBARAO UPPALURI

	 	JUAN RODRIGUEZ
	/s/ Tibor Hollo

	 	/s/ Elliott Harris
	 

	 	 
	TIBOR HOLLO

	 	ELLIOTT HARRIS
	/s/ Stephen H. Liu

	 	/s/ Dennis Scholl
	 

	 	 
	STEPHEN H. LIU

	 	DENNIS SCHOLL
	/s/ Richard Rosenstock

	 	/s/ Fred Johnson
	 

	 	 
	RICHARD ROSENSTOCK

	 	FRED JOHNSON
	/s/ David Farina

	 	

	 

	 	

	DAVID FARINAEX-10.29

 Exhibit 10.29 

THESE SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”).
THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED, OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT, OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT REGISTRATION IS NOT
REQUIRED UNDER THE SECURITIES ACT OR UNLESS SOLD PURSUANT TO RULE 144 UNDER THE SECURITIES ACT. 
 GREAT BASIN SCIENTIFIC, INC.

 WARRANT TO PURCHASE COMMON STOCK 
  

			
	Warrant No. [    ]	  	[                    ]

 Void after
[                    ] 

THIS CERTIFIES THAT, for value received,
[                    ], or assigns (the “Holder”), is entitled to subscribe for and purchase at the Exercise Price (defined below) from
Great Basin Scientific, Inc., a Delaware corporation, with its principal office at 405 South Main Street, Suite 810, Salt Lake City, Utah 84111 (the “Company”) shares of Common Stock of the Company. 

This Warrant is issued pursuant to the terms of that certain Secured Note and Warrant Purchase Agreement (the “Purchase Agreement”)
dated as of March 4th, 2009, in connection with the Company’s issuance to the Holder of a Secured Convertible Promissory Note dated as of the date of this Warrant (the “Note”),
for the principal amount of [                    ]. In the event the consideration provided by the Holder to the Company pursuant to the Purchase
Agreement as of the date hereof is equal to Holder’s Pro Rata Amount (as defined in the Purchase Agreement), the number of shares of Common Stock that Holder may purchase by exercising this Warrant is one (1) share of Common Stock of the
Company for each one (1) share of Equity Securities (as defined in the Note) the Holder receives upon conversion of the Note. In the event the consideration provided by the Holder to the Company pursuant to the Purchase Agreement as of the date
hereof is less than the Holder’s Pro Rata Amount, the number of shares of Common Stock that the Holder may purchase by exercising this Warrant is one half
( 1⁄2) share of Common Stock of the Company (rounded down to the nearest whole share) for each one (1) share of Equity Securities the Holder receives
upon conversion of the Note. 
 1. DEFINITIONS. As used herein, the following terms shall have the
following respective meanings: 
 (a) “Exercise Period” shall mean the period commencing with the date hereof and ending
seven (7) years later, unless sooner terminated as provided below. 
 (b) “Exercise Price” shall mean
$[        ] per share of Common Stock. 
 (c) “Exercise Shares” shall mean the
shares of the Common Stock issuable upon exercise of this Warrant, subject to adjustment pursuant to the terms herein, including but not limited to adjustment pursuant to Section 5 below. 

 2. EXERCISE OF WARRANT. The
rights represented by this Warrant may be exercised in whole or in part at any time during the Exercise Period, by delivery of the following to the Company at its address set forth above (or at such other address as it may designate by notice in
writing to the Holder): 
 (a) An executed Notice of Exercise in the form attached hereto; 

(b) Payment of the Exercise Price in cash, by check or pursuant to Section 2.1; and 

(c) This Warrant. 
 Upon
the exercise of the rights represented by this Warrant, a certificate or certificates for the Exercise Shares so purchased, registered in the name of the Holder or persons affiliated with the Holder, if the Holder so designates, shall be issued and
delivered to the Holder within a reasonable time after the rights represented by this Warrant shall have been so exercised. In the event that this Warrant is being exercised for less than all of the then-current number of Exercise Shares purchasable
hereunder, the Company shall, concurrently with the issuance by the Company of the number of Exercise Shares for which this Warrant is then being exercised, issue a new Warrant exercisable for the remaining number of Exercise Shares purchasable
hereunder. 
 The person in whose name any certificate or certificates for Exercise Shares are to be issued upon exercise of this Warrant
shall be deemed to have become the holder of record of such shares on the date on which this Warrant was surrendered and payment of the Exercise Price was made, irrespective of the date of delivery of such certificate or certificates, except that,
if the date of such surrender and payment is a date when the stock transfer books of the Company are closed, such person shall be deemed to have become the holder of such shares at the close of business on the next succeeding date on which the stock
transfer books are open. 
 2.1. Net Exercise. If the fair market value of one share of the Common Stock of the Company is greater
than the Exercise Price (at the date of calculation as set forth below), in lieu of exercising this Warrant by payment of cash, the Holder may elect to receive shares equal to the value (as determined below) of this Warrant (or the portion thereof
being cancelled) by surrender of this Warrant at the principal office of the Company together with the properly endorsed Notice of Exercise in which event the Company shall issue to the Holder a number of shares of Common Stock computed using the
following formula: 
 X = Y (A – B) 

A 
  

			
	Where X =	  	the number of shares of Common Stock to be issued to the Holder

			
		
	Y =	  	the number of shares of Common Stock purchasable under the Warrant or, if only a portion of the Warrant is being exercised, the portion of the Warrant being canceled (at the date of such calculation)

  
 2 

			
	 A =
	  	the fair market value of one share of the Company’s Common Stock (at the date of such calculation)
		
	 B =
	  	Exercise Price (as may be adjusted to the date of such calculation)

 For purposes of the above calculation, the fair market value of one share of Common Stock shall be determined
by the Company’s Board of Directors in good faith; provided, however, that in the event that this Warrant is exercised pursuant to this Section 2.1 in connection with the Company’s initial public offering of its Common Stock, the fair
market value per share shall be the product of (i) the per share offering price to the public of the Company’s initial public offering, and (ii) the number of shares of Common Stock into which each share of Common Stock is convertible
at the time of such exercise. 
 3. COVENANTS OF THE COMPANY. 

3.1. Covenants as to Exercise Shares. The Company covenants and agrees that all Exercise Shares that may be issued upon the exercise of
the rights represented by this Warrant will, upon issuance, be validly issued and outstanding, fully paid and nonassessable, and free from all taxes, liens and charges with respect to the issuance thereof. The Company further covenants and agrees
that the Company will prior to the exercise of this Warrant, have authorized and reserved, free from preemptive rights, a sufficient number of shares of its Common Stock to provide for the exercise of the rights represented by this Warrant. 

3.2. Notices of Record Date. In the event of any taking by the Company of a record of the holders of any class of securities for the
purpose of determining the holders thereof who are entitled to receive any dividend (other than a cash dividend which is the same as cash dividends paid in previous quarters) or other distribution, the Company shall mail to the Holder, at least ten
(10) days prior to the date specified herein, a notice specifying the date on which any such record is to be taken for the purpose of such dividend or distribution. 

4. REPRESENTATIONS OF HOLDER. 

4.1. Acquisition of Warrant for Personal Account. The Holder represents and warrants that it is acquiring the Warrant and the Exercise
Shares solely for its account for investment and not with a view to or for sale or distribution of said Warrant or Exercise Shares or any part thereof The Holder also represents that the entire legal and beneficial interests of the Warrant and
Exercise Shares the Holder is acquiring is being acquired for, and will be held for, its account only. 
 4.2. Securities Are Not
Registered. 
 (a) The Holder understands that the Warrant and the Exercise Shares have not been registered under the Securities
Act of 1933, as amended (the “Securities Act”) on the basis that no distribution or public offering of the stock of the Company is to be effected. The Holder realizes that the basis for the exemption may not be present if, notwithstanding
its representations, the Holder has a present intention of acquiring the securities for a fixed or determinable period in the future, selling (in connection with a distribution or otherwise), granting any participation in, or otherwise distributing
the securities. The Holder has no such present intention. 

  
 3 

 (b) The Holder recognizes that the Warrant and the Exercise Shares must be held
indefinitely unless they are subsequently registered under the Securities Act or an exemption from such registration is available. The Holder recognizes that the Company has no obligation to register the Warrant or the Exercise Shares of the
Company, or to comply with any exemption from such registration. 
 (c) The Holder is aware that neither the Warrant nor the
Exercise Shares may be sold pursuant to Rule 144 adopted under the Securities Act unless certain conditions are met. Holder is aware that the conditions for resale set forth in Rule 144 have not been satisfied and that the Company
presently has no plans to satisfy these conditions in the foreseeable future. 
 4.3. Disposition of Warrant and Exercise Shares.

 (a) The Holder further agrees not to make any disposition of all or any part of the Warrant or Exercise Shares in any event
unless and until: 
 (i) The Company shall have received a letter secured by the Holder from the Securities and Exchange Commission
stating that no action will be recommended to the Commission with respect to the proposed disposition; 
 (ii) There is then in
effect a registration statement under the Securities Act covering such proposed disposition and such disposition is made in accordance with said registration statement; or 

(iii) The Holder shall have notified the Company of the proposed disposition and shall have furnished the Company with a detailed
statement of the circumstances surrounding the proposed disposition, and if reasonably requested by the Company, the Holder shall have furnished the Company with an opinion of counsel, reasonably satisfactory to the Company, for the Holder to the
effect that such disposition will not require registration of such Warrant or Exercise Shares under the Securities Act or any applicable state securities laws. 

(b) The Holder understands and agrees that all certificates evidencing the shares to be issued to the Holder may bear the following
legend: 
 THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THEY MAY
NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO THE SECURITIES UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED.

  
 4 

 4.4. Accredited Investor Status. The Holder is an “accredited investor” as
defined in Regulation D promulgated under the Securities Act. 
 4.5. Further Representations by Foreign Investors. 

(a) If the Holder is not a United States person, the Holder hereby represents that he or she has satisfied himself or herself as to the
full observance of the laws of his or her jurisdiction in connection with the acquisition of the Warrant and the Exercise Shares, including (i) the legal requirements within his jurisdiction for the purchase of the Warrant and the Exercise
Shares, (ii) any foreign exchange restrictions applicable to such purchase, (iii) any governmental or other consents that may need to be obtained, and (iv) the income tax and other tax consequences, if any, that may be relevant to the
purchase, holding, redemption, sale, or transfer of the Warrant and the Exercise Shares. Such Lender’s subscription and payment for, and his or her continued beneficial ownership of the Warrant and the Exercise Shares, will not violate any
applicable securities or other laws of his or her jurisdiction. 
 (b) If the Holder does not reside in and is not a citizen of the
United States, it shall be deemed a “Foreign Investor.” As a Foreign Investor the Holder hereby represents, warrants and covenants to the Company, the following: 

(i) Neither the Holder nor any person for the account of whom it is acting, including the estate of any such person, a trust of which
any such person is a beneficiary, or a corporation, partnership, trust or other entity organized under the laws of the United States of America, its territories and possessions and all areas under the jurisdiction of the United States of America, is
a citizen or resident of the United States of America (a “U.S. Person”). 
 (ii) the Holder further agrees not to make any
disposition of all or any portion of the Warrant or Exercise Shares to a U.S. Person unless and until: 
 (1) Such disposition is in
accordance with Regulation S promulgated under the Securities Act, or 
 (2) There is then in effect a registration statement under
the Securities Act covering such proposed disposition and such disposition is made in accordance with such registration statement, or 

(3) It shall have notified the Company of the proposed disposition and shall have furnished the Company with a detailed statement of
the circumstances surrounding the proposed disposition, and if reasonably requested by the Company, shall have furnished the Company with an opinion of counsel, reasonably satisfactory to the Company, that such disposition will not require
registration under the Securities Act. 

  
 5 

 5. ADJUSTMENT OF EXERCISE PRICE
AND NUMBER OF EXERCISE SHARES. In the event of changes in the outstanding Common Stock of the Company by reason of stock dividends, split-ups,
recapitalizations, reclassifications, combinations or exchanges of shares, separations, reorganizations, liquidations, or the like, the number and class of shares available under the Warrant in the aggregate and the Exercise Price shall be
correspondingly adjusted to give the Holder of the Warrant, on exercise for the same aggregate Exercise Price, the total number, class, and kind of shares as the Holder would have owned had the Warrant been exercised prior to the event and had the
Holder continued to hold such shares until after the event requiring adjustment; provided, however, that such adjustment shall not be made with respect to, and this Warrant shall terminate if not exercised prior to, the events set forth in
Section 7 below. The form of this Warrant need not be changed because of any adjustment in the number of Exercise Shares subject to this Warrant. 

6. FRACTIONAL SHARES. No fractional shares shall be issued upon the exercise of this
Warrant as a consequence of any adjustment pursuant hereto. All Exercise Shares (including fractions) issuable upon exercise of this Warrant may be aggregated for purposes of determining whether the exercise would result in the issuance of any
fractional share. If, after aggregation, the exercise would result in the issuance of a fractional share, the Company shall, in lieu of issuance of any fractional share, pay the Holder otherwise entitled to such fraction a sum in cash equal to the
product resulting from multiplying the then current fair market value of an Exercise Share by such fraction. 
 7.
EXPIRATION OF WARRANT. This Warrant shall expire and be of no further force or effect upon the earliest of: (a) the termination date indicated on the first page hereof;
(b) the sale, exclusive license or other disposition of all or substantially all of the assets of the Company; or (c) the acquisition of the Company by means of a merger, consolidation, reorganization or stock sale resulting in the
exchange of the outstanding shares of the Company for securities or consideration issued, or caused to be issued, by the acquiring corporation or its subsidiary after which stockholders of the Company immediately prior to the effectiveness of such
transaction own less than 50% of the shares of equity securities on an as-converted basis of the surviving entity after giving effect to such transaction. In the event of any anticipated termination of this Warrant pursuant to Sections 7(b) or
7(c), the Company shall use commercially reasonable efforts to give the holder written notice of such anticipated termination at least seven (7) days prior to the effectiveness of the event causing such termination together with a description
of the event giving rise to such termination, the value of any securities or other consideration to be received or issued in such transaction and the anticipated effective date of such event. 

  
 6 

 8. MARKET STAND-OFF
AGREEMENT. The Holder shall not sell, dispose of, transfer, make any short sale of, grant any option for the purchase of, or enter into any hedging or similar transaction with the same economic effect as a sale, any
Common Stock (or other securities) of the Company held by Holder, for a period of time specified by the managing underwriter(s) following the effective date of a registration statement of the Company filed under the Securities Act; provided however,
that such agreement shall not be required unless all officers, directors and holders of one percent (1%) or more of the outstanding voting securities of the Company enter into similar agreements. Holder agrees to execute and deliver such other
agreements as may be reasonably requested by the Company and/or the managing underwriter(s) which are consistent with the foregoing or which are necessary to give further effect thereto. In order to enforce the foregoing covenant, the Company may
impose stop-transfer instructions with respect to such Common Stock (or other securities) until the end of such period. The underwriters of the Company’s stock are intended third party beneficiaries of this Section 8 and shall have the
right, power and authority to enforce the provisions hereof as though they were a party hereto. 
 9. NO
IMPAIRMENT. The Company will not, by amendment of its certificate of incorporation or through any reclassification, capital reorganization, consolidation, merger, sale or conveyance of assets, dissolution,
liquidation, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance of performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in
the taking of all such action as may be necessary or appropriate in order to protect the rights of the Holder. 
 10. NO
STOCKHOLDER RIGHTS. This Warrant in and of itself shall not entitle the Holder to any voting rights or other rights as a stockholder of the Company. 

11. TRANSFER OF WARRANT. Subject to compliance with any applicable
securities laws and the restrictions set forth in this Warrant, this Warrant and all rights hereunder are transferable, in whole or in part, only to: (i) a spouse or member of the Holder’s family, or to a custodian, trustee, executor, or
other fiduciary for the account of the Holder’s spouse or members of the Holder’s family, or to a trust for the Holder’s own self, or a charitable remainder trust, or (ii) a subsidiary, parent, partner, limited partner, retired
partner, member, retired member, affiliate or stockholder of Holder upon surrender of this Warrant at the principal office of the Company, together with an assignment form of this Warrant substantially in the form attached hereto duly executed by
the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. 
 12.
LOST, STOLEN, MUTILATED OR DESTROYED WARRANT. If this Warrant is lost, stolen, mutilated or destroyed, the Company may, on such terms as to
indemnity or otherwise as it may reasonably impose (which shall, in the case of a mutilated Warrant, include the surrender thereof), issue a new Warrant of like denomination and tenor as the Warrant so lost, stolen, mutilated or destroyed. Any such
new Warrant shall constitute an original contractual obligation of the Company, whether or not the allegedly lost, stolen, mutilated or destroyed Warrant shall be at any time enforceable by anyone. 

  
 7 

 13.NOTICES, ETC. All notices required or
permitted hereunder shall be in writing and shall be deemed effectively given: (a) upon personal delivery to the party to be notified, (b) when sent by confirmed telex or facsimile if sent during normal business hours of the recipient, if
not, then on the next business day, (c) five (5) days after having been sent by registered or certified mail, return receipt requested, postage prepaid, or (d) one (1) day after deposit with a nationally recognized overnight
courier, specifying next day delivery, with written verification of receipt. All communications shall be sent to the Company at the address listed on the signature page and to the Holder at such address of the Holder on Schedule 1 of the
Purchase Agreement or at such other address as the Company or the Holder may designate by ten (10) days advance written notice to the other parties hereto. 

14. ACCEPTANCE. Receipt of this Warrant by the Holder shall constitute acceptance of and agreement to all
of the terms and conditions contained herein. 
 15. GOVERNING LAW. This Warrant and all
rights, obligations and liabilities hereunder shall be governed by and construed under the corporate laws of the State of Delaware, and as to all matters other than those to which corporate law applies, this Warrant shall be governed by the laws of
the State of Delaware as they apply to contracts entered into wholly to be performed within the State of Delaware by residents thereof. 

[Remainder of Page Intentionally Left Blank] 

  
 8 

 IN WITNESS WHEREOF, the
Company has caused this Warrant to be executed by its duly authorized officer as of the date shown on the first page. 
  

			
	GREAT BASIN SCIENTIFIC, INC.
		
	By:	 	  

	Name:	 	  

	Title:	 	  

		
	Address:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00235-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00235-of-00352.parquet"}]]